Aurobindo Pharma

quarterly
yearly
ParticularsJun '21Sep '21Dec '21Mar '22Jun '22
Revenue5,7025,9426,0025,8096,236
Expenses4,7725,0495,2505,2515,551
EBITDA929.69892.51752.01558.07685.23
EBIT650.00598.30452.96304.50405.72
Profit Before Tax1,018967.62793.78593.63678.99
Net Profit769.97696.99604.73576.46520.54
Financial Ratios
Operating Profit Margin16.30%15.02%12.53%9.61%10.99%
Net Profit Margin13.50%11.73%10.08%9.92%8.35%
Earning Per Share (Diluted)13.1411.899.8712.538.88
Dividends Per Share1.501.501.504.50NA
ⓒ 2016-2022 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.3.8
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI